Medicare Enrolled
Dr. Cory Rubin, M.D.
Clinical & Laboratory Dermatological Immunology Physician · Waterford, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rubin
Dr. Cory Rubin is a clinical & laboratory dermatological immunology physician in Waterford, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rubin performed 5,980 Medicare services across 818 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rubin received a total of $3,774,299 from 61 pharmaceutical and/or device companies across 4282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical & laboratory dermatological immunology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in MI
$3,774,299 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,980
Medicare services
Top 25% in MI for clinical & laboratory dermatological immunology physician
818
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~315 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, tildrakizumab, 1 mg | 4,200 | $108 | $211 |
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
480 | $5 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
401 | $95 | $197 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
263 | $67 | $139 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
166 | $85 | $175 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
162 | $41 | $104 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
87 | $120 | $258 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
69 | $72 | $156 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $74 | $174 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
50 | $10 | $22 |
| Destruction of skin growth, 15 or more growths | 25 | $102 | $204 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
12 | $95 | $194 |
| Complex or multiple skin abscess drainage A procedure to drain one or more skin abscesses that are complex in nature. This involves opening and cleaning the infected pockets under the skin. |
11 | $168 | $333 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,774,299
Total received (2018-2024)
Avg $539,186/year across 7 years
Top 33% in MI for clinical & laboratory dermatological immunology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
4,282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,725,278 (98.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$44,325 (1.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,696 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$810,419
2023
$783,227
2022
$543,351
2021
$269,580
2020
$289,062
2019
$605,794
2018
$472,867
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SUN PHARMACEUTICAL INDUSTRIES INC.
$133,860
Regeneron Healthcare Solutions, Inc.
$110,010
UCB, Inc.
$93,137
Dermavant Sciences, Inc.
$90,404
GENZYME CORPORATION
$88,641
ABBVIE INC.
$83,299
Galderma Laboratories, L.P.
$48,382
Incyte Corporation
$47,894
Amgen Inc.
$35,796
Boehringer Ingelheim Pharmaceuticals, Inc.
$19,702
LEO Pharma Inc.
$19,338
PFIZER INC.
$15,579
Verrica Pharmaceuticals Inc.
$9,580
Arcutis Biotherapeutics, Inc.
$9,097
Novartis Pharmaceuticals Corporation
$5,026
E.R. Squibb & Sons, L.L.C.
$222
Janssen Biotech, Inc.
$160
Lilly USA, LLC
$135
Organon Llc
$41
Smith+Nephew, Inc.
$33
Genentech USA, Inc.
$27
Ortho Dermatologics, a division of Bausch Health US, LLC
$24
Solta Medical, a division of Bausch Health US, LLC
$22
Janssen Scientific Affairs, LLC
$10
Top 3 companies account for 41.6% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$571,753
GENZYME CORPORATION
$459,499
Novartis Pharmaceuticals Corporation
$326,697
UCB, Inc.
$238,047
Incyte Corporation
$213,691
Galderma Laboratories, L.P.
$208,034
Celgene Corporation
$194,429
Sun Pharmaceutical Industries Inc.
$174,768
PFIZER INC.
$174,585
ABBVIE INC.
$168,040
Dermavant Sciences, Inc.
$165,834
SUN PHARMACEUTICAL INDUSTRIES INC.
$141,766
E.R. Squibb & Sons, L.L.C.
$130,855
LEO Pharma Inc.
$118,397
Amgen Inc.
$117,708
AbbVie Inc.
$87,173
AbbVie, Inc.
$77,054
Boehringer Ingelheim Pharmaceuticals, Inc.
$73,854
Ortho Dermatologics, a division of Bausch Health US, LLC
$35,200
Genentech USA, Inc.
$31,206
Helsinn Therapeutics (U.S.), Inc.
$18,555
Pfizer Inc.
$13,064
Verrica Pharmaceuticals Inc.
$9,618
Arcutis Biotherapeutics, Inc.
$9,207
Promius Pharma LLC
$4,673
Janssen Biotech, Inc.
$3,236
Bayer HealthCare Pharmaceuticals Inc.
$2,783
Almirall LLC
$945
NOVARTIS PHARMACEUTICALS CORPORATION
$900
Biofrontera Inc.
$524
Lilly USA, LLC
$368
SANOFI-AVENTIS U.S. LLC
$227
Mayne Pharma Inc.
$206
Genentech, Inc.
$200
Smith+Nephew, Inc.
$181
Encore Dermatology Inc.
$91
Janssen Scientific Affairs, LLC
$86
DERMIRA, INC.
$85
VYNE Pharmaceuticals Inc.
$77
Journey Medical Corporation
$74
Smith & Nephew, Inc.
$71
Sandoz Inc.
$50
Mylan Institutional Inc.
$47
MAYNE PHARMA INC.
$47
Myriad Genetic Laboratories, Inc.
$47
Kyowa Kirin, Inc.
$46
Organon Llc
$41
Ra Medical Systems, Inc.
$36
EPI Health, LLC
$32
Solta Medical, a division of Bausch Health US, LLC
$22
Fresenius Kabi USA, LLC
$21
AstraZeneca Pharmaceuticals LP
$20
Mission Pharmacal Company
$19
Organon LLC
$19
DUSA Pharmaceuticals, Inc.
$17
Paratek Pharmaceuticals, Inc.
$15
Taro Pharmaceuticals USA, Inc.
$15
Mylan Pharmaceuticals Inc.
$13
Melinta Therapeutics, Inc.
$13
STRATA Skin Sciences, Inc.
$11
MEDAC PHARMA, INC.
$11
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
0.25% · ABSORICA · ABSORICA LD · ACTIMMUNE · ADBRY · AFINITOR · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · Ameluz · BLU-U · BOTOX · Baxdela · Bimzelx · CIBINQO · CLEAR+BRILLIANT · CLODERM · COLLAGENASE SANTYL · COSENTYX · CYLTEZO · Cimzia · Cloderm Cream · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · EFUDEX · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · EVUSHELD · Enbrel · Erivedge · FINACEA · Finacea · HADLIMA · HUMIRA · HYRIMOZ · Hulio · Humira · ILARIS · ILUMYA · Ilumya · Impoyz · JUBLIA · KERYDIN · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · LUZU · NO PRODUCT DISCUSSED · NUZYRA · OLUMIANT · OPZELURA · ORACEA · Odomzo · Olux · Otezla · PICATO · Pharos · Poteligeo · Promiseb Complete · QBREXZA · REMICADE · RENFLEXIS · RETIN-A-MICRO · RINVOQ · Rasuvo · SEYSARA · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · STELARA · Santyl · Sernivo Spray · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TOPICORT (desoximetasone) Topical Spray · TREMFYA · TRIANEX 0.05% · Tremfya · Trianex · VALCHLOR · VTAMA · Winlevi · XALKORI · XELJANZ · XOLAIR · XTRAC · Xolair · YCANTH · ZILXI · Zoryve · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in clinical & laboratory dermatological immunology physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Clinical & laboratory dermatological immunology physicians within 10 mi
5
Per 100K population
0.4
County median income
$95,296
Nearest hospital
TRINITY HEALTH OAKLAND HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rubin is a mixed practice specialist, with above-average Medicare volume (top 25% in MI), with speaking/promotional industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rubin experienced with injection, tildrakizumab, 1 mg?
Based on Medicare claims data, Dr. Rubin performed 4,200 injection, tildrakizumab, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $3,774,299 from 61 companies across 4,282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other clinical & laboratory dermatological immunology physicians in Waterford?
Dr. Rubin's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Clinical & Laboratory Dermatological Immunology Physicians in Waterford
Browse clinical & laboratory dermatological immunology physicians in Waterford ranked by procedure volume and transparency data.
Highest volume
Top Clinical & Laboratory Dermatological Immunology Physicians in MI
Clinical & laboratory dermatological immunology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Clinical & Laboratory Dermatological Immunology Physicians in MI
Which MI clinical & laboratory dermatological immunology physicians receive the most from drug and device companies.
By company
Regeneron Healthcare Solutions, Inc. Payments to Doctors
See all physicians who received payments from Regeneron Healthcare Solutions, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology